Shaanxi Meibang Pharmaceutical Group Co., Ltd.
SSE:605033.SS
16.97 (CNY) • At close May 6, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||
| Current Assets: | ||||||||
| Cash & Cash Equivalents
| 267.863 | 481.172 | 318.247 | 254.388 | 199.412 | 207.739 | 70.265 | 43.211 |
| Short Term Investments
| 388.467 | 0 | 79.932 | 148 | 0 | 12 | 20 | 82.92 |
| Cash and Short Term Investments
| 656.33 | 481.172 | 398.179 | 402.388 | 199.412 | 219.739 | 70.265 | 43.211 |
| Net Receivables
| 79.763 | 148.678 | 189.083 | 92.491 | 25.841 | 18.577 | 46.039 | 16.697 |
| Inventory
| 264.714 | 353.698 | 457.289 | 559.557 | 277.965 | 236.07 | 294.481 | 218.902 |
| Other Current Assets
| 95.905 | 87.879 | 142.362 | 136.298 | 128.786 | 57.567 | 78.505 | 147.663 |
| Total Current Assets
| 1,096.713 | 1,071.793 | 1,188.412 | 1,192.778 | 606.163 | 536.446 | 478.374 | 426.473 |
| Non-Current Assets: | ||||||||
| Property, Plant & Equipment, Net
| 613.669 | 457.073 | 185.841 | 115.721 | 96.126 | 83.55 | 85.389 | 60.544 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 118.478 | 83.231 | 12.273 | 7.705 | 7.941 | 8.27 | 8.698 | 6.806 |
| Goodwill and Intangible Assets
| 118.478 | 83.231 | 12.273 | 7.705 | 7.941 | 8.27 | 8.698 | 6.806 |
| Long Term Investments
| 0 | 0.417 | 0 | 0.971 | 0 | 0.103 | 0.28 | 0.456 |
| Tax Assets
| 15.705 | 16.434 | 12.416 | 4.264 | 3.307 | 4.157 | 3.959 | 1.433 |
| Other Non-Current Assets
| 17.467 | 63.054 | 161.552 | 141.943 | 72.329 | 33.442 | 9.077 | 13.943 |
| Total Non-Current Assets
| 765.32 | 620.209 | 372.083 | 270.603 | 179.703 | 129.522 | 107.403 | 83.182 |
| Total Assets
| 1,862.032 | 1,692.002 | 1,560.495 | 1,463.381 | 785.867 | 665.968 | 585.777 | 509.655 |
| Liabilities & Equity: | ||||||||
| Current Liabilities: | ||||||||
| Account Payables
| 305.843 | 171.772 | 102.679 | 22.72 | 84.027 | 33.785 | 60.553 | 87.25 |
| Short Term Debt
| 0 | 1.001 | 0 | 27.051 | 0 | 40.04 | 27 | 49 |
| Tax Payables
| 2.676 | 3.438 | 4.388 | 6.4 | 1.569 | 3.678 | 2.177 | 6.308 |
| Deferred Revenue
| 0 | 0 | 151.395 | 279.042 | 195.505 | 31.183 | 2.177 | 30.371 |
| Other Current Liabilities
| 307.74 | 284.694 | 111.256 | 161.65 | 225.136 | 166.895 | 199.944 | 177.34 |
| Total Current Liabilities
| 616.258 | 460.906 | 369.718 | 437.066 | 310.732 | 275.58 | 291.85 | 319.898 |
| Non-Current Liabilities: | ||||||||
| Long Term Debt
| 72 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 3.245 | 0 | 0.775 | 0.868 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 4.61 | 4.778 | 5.633 | 5.416 | 4.328 | 3.576 | 2.941 | 0 |
| Other Non-Current Liabilities
| 41.257 | 112.153 | 98.016 | 53.947 | 21.441 | 16.18 | 14.611 | 9.33 |
| Total Non-Current Liabilities
| 121.113 | 116.931 | 104.424 | 59.363 | 25.769 | 19.756 | 17.552 | 9.33 |
| Total Liabilities
| 737.371 | 577.837 | 474.142 | 496.429 | 336.501 | 295.336 | 309.402 | 329.227 |
| Equity: | ||||||||
| Preferred Stock
| 0 | 0 | 6.927 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 135.2 | 135.2 | 137.793 | 135.2 | 101.4 | 101.4 | 98.4 | 90 |
| Retained Earnings
| 501.557 | 497.924 | 473.143 | 359.706 | 237.775 | 163.567 | 90.691 | 64.475 |
| Accumulated Other Comprehensive Income/Loss
| 0 | 21.672 | -6.927 | 12.677 | 110.191 | 105.665 | 87.284 | 0 |
| Other Total Stockholders Equity
| 487.904 | 459.369 | 475.417 | 459.369 | 110.191 | 105.665 | 87.284 | 25.953 |
| Total Shareholders Equity
| 1,124.661 | 1,114.166 | 1,086.353 | 966.952 | 449.366 | 370.632 | 276.375 | 180.428 |
| Total Equity
| 1,124.661 | 1,114.166 | 1,086.353 | 966.952 | 449.366 | 370.632 | 276.375 | 180.428 |
| Total Liabilities & Shareholders Equity
| 1,862.032 | 1,692.002 | 1,560.495 | 1,463.381 | 785.867 | 665.968 | 585.777 | 509.655 |